Table of Contents
ISRN Hepatology
Volume 2013, Article ID 256426, 6 pages
http://dx.doi.org/10.1155/2013/256426
Review Article

Mild Hypertransaminasemia in Primary Care

1Department of Medicine, College of Medicine and Health Science, Sultan Qaboos University, P.O. Box 35, 123 Muscat, Oman
2Department of Gastroenterology, Jewish General Hospital, McGill University, Montreal, QC, Canada H3T 1E2

Received 5 February 2013; Accepted 12 March 2013

Academic Editors: C. S. Hsu, D. G. Kim, and C. Kordes

Copyright © 2013 Said A. Al-Busafi and Nir Hilzenrat. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Pratt and M. M. Kaplan, “Evaluation of abnormal liver-enzyme results in asymptomatic patients,” The New England Journal of Medicine, vol. 342, no. 17, pp. 1266–1271, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. G. N. Ioannou, E. J. Boyko, and S. P. Lee, “The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999–2002,” American Journal of Gastroenterology, vol. 101, no. 1, pp. 76–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Sherwood, I. Lyburn, S. Brown, and S. Ryder, “How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact,” British Medical Journal, vol. 322, no. 7281, pp. 276–278, 2001. View at Google Scholar · View at Scopus
  4. R. M. Green and S. Flamm, “AGA technical review on the evaluation of liver chemistry tests,” Gastroenterology, vol. 123, no. 4, pp. 1367–1384, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Y. Minuk, “Canadian association of gastroenterology practice guidelines: evaluation of abnormal liver enzyme tests,” Canadian Journal of Gastroenterology, vol. 12, no. 6, pp. 417–421, 1998. View at Google Scholar · View at Scopus
  6. R. Rej, “Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues,” Clinical Chemistry, vol. 24, no. 11, pp. 1971–1979, 1978. View at Google Scholar · View at Scopus
  7. L. W. Kundrotas and D. J. Clement, “Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors,” Digestive Diseases and Sciences, vol. 38, no. 12, pp. 2145–2150, 1993. View at Google Scholar · View at Scopus
  8. U. L. Mathiesen, L. E. Franzén, A. Frydén, U. Foberg, and G. Bodemar, “The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients,” Scandinavian Journal of Gastroenterology, vol. 34, no. 1, pp. 85–91, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. B. Williams and J. H. Hoofnagle, “Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis,” Gastroenterology, vol. 95, no. 3, pp. 734–739, 1988. View at Google Scholar · View at Scopus
  10. J. A. Cohen and M. M. Kaplan, “The SGOT/SGPT ratio. An indicator of alcoholic liver disease,” Digestive Diseases and Sciences, vol. 24, no. 11, pp. 835–838, 1979. View at Google Scholar · View at Scopus
  11. M. Krier and A. Ahmed, “The asymptomatic outpatient with abnormal liver function tests,” Clinics in Liver Disease, vol. 13, no. 2, pp. 167–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Mofrad, M. J. Contos, M. Haque et al., “Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values,” Hepatology, vol. 37, no. 6, pp. 1286–1292, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. O. Shakil, C. Conry-Cantilena, H. J. Alter et al., “Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features,” Annals of Internal Medicine, vol. 123, no. 5, pp. 330–337, 1995. View at Google Scholar · View at Scopus
  14. M. M. Haber, A. B. West, A. D. Haber, and A. Reuben, “Relationship of aminotransferases to liver histological status in chronic hepatitis C,” American Journal of Gastroenterology, vol. 90, no. 8, pp. 1250–1257, 1995. View at Google Scholar · View at Scopus
  15. W. R. Kim, S. L. Flamm, A. M. di Bisceglie, and H. C. Bodenheimer, “Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease,” Hepatology, vol. 47, no. 4, pp. 1363–1370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Dutta, C. Saha, C. S. Johnson, and N. Chalasani, “Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study,” Hepatology, vol. 50, no. 6, pp. 1957–1962, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. B. A. Neuschwander-Tetri, A. Ünalp, and M. H. Creer, “Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels,” Archives of Internal Medicine, vol. 168, no. 6, pp. 663–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. E. Ruhl and J. E. Everhart, “Upper limits of normal for alanine aminotransferase activity in the United States population,” Hepatology, vol. 55, pp. 447–454, 2012. View at Publisher · View at Google Scholar
  19. D. R. Dufour, J. A. Lott, F. S. Nolte, D. R. Gretch, R. S. Koff, and L. B. Seeff, “Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests,” Clinical Chemistry, vol. 46, no. 12, pp. 2027–2049, 2000. View at Google Scholar · View at Scopus
  20. D. Prati, E. Taioli, A. Zanella et al., “Updated definitions of healthy ranges for serum alanine aminotransferase levels,” Annals of Internal Medicine, vol. 137, no. 1, pp. 1–10, 2002. View at Google Scholar · View at Scopus
  21. H. C. Kim, C. M. Nam, S. H. Jee, K. H. Han, D. K. Oh, and I. Suh, “Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study,” British Medical Journal, vol. 328, no. 7446, pp. 983–986, 2004. View at Google Scholar · View at Scopus
  22. A. S. F. Lok and B. J. McMahon, “Chronic hepatitis B,” Hepatology, vol. 45, no. 2, pp. 507–539, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. H. L. Tae, W. R. Kim, J. T. Benson, T. M. Therneau, and L. J. Melton, “Serum aminotransferase activity and mortality risk in a United States community,” Hepatology, vol. 47, no. 3, pp. 880–887, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Goessling, J. M. Massaro, R. S. Vasan, R. B. D'Agostino, R. C. Ellison, and C. S. Fox, “Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease,” Gastroenterology, vol. 135, no. 6, pp. 1935.e1–1944.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Lazo, E. Selvin, and J. M. Clark, “Brief communication: clinical implications of short-term variability in liver function test results,” Annals of Internal Medicine, vol. 148, no. 5, pp. 348–352, 2008. View at Google Scholar · View at Scopus
  26. J. M. Clark, F. L. Brancati, and A. M. Diehl, “The prevalence and etiology of elevated aminotransferase levels in the United States,” American Journal of Gastroenterology, vol. 98, no. 5, pp. 960–967, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Daniel, T. Ben-Menachem, G. Vasudevan, C. K. Ma, and M. Blumenkehl, “Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients,” American Journal of Gastroenterology, vol. 94, no. 10, pp. 3010–3014, 1999. View at Publisher · View at Google Scholar · View at Scopus